Medicine & Health

Timothy M. Miller, MD, PhD, a leading researcher in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), has been named the David Clayson Professor of Neurology at the School of Medicine. The professorship was established in 2001 through a bequest from David Clayson, PhD, to support innovative research into treatments for ALS.

Transit stops close to home and workplace incentives are associated with higher likelihood that commuters will choose public transportation, according to research from the Brown School at Washington University in St. Louis and Washington University School of Medicine in St. Louis. The study is co-authored by Aaron Hipp, PhD, assistant professor at the Brown School.

John W. Olney, MD, the John P. Feighner Professor of Psychiatry and professor of pathology and immunology, died Tuesday, April 14, 2015 at his home in St. Louis after a battle with lung cancer and amyotrophic lateral sclerosis (ALS). He was 83.

Smokers with a specific genetic variation are more likely to keep smoking longer than those who don’t have the gene variant. They’re also more likely to be diagnosed with lung cancer at a younger age, according to new research from Laura Jean Bierut, MD (left), and Li-Shiun Chen, MD, at Washington University School of Medicine in St. Louis.

A new study finds that that 1.2 percent of American preschool children on Medicaid are using psychotropic drugs, including antidepressants, mood stabilizers and medications for attention-deficit disorder. Using 2000-2003 Medicaid Analytic Extract data from 36 states, a group of researchers at the Brown School at Washington University in St. Louis and at Washington University School of Medicine in St. Louis found preschoolers are receiving psychotropic medications despite limited evidence supporting safety or efficacy.

Opening the door for potential treatments for the deadly Ebola virus, scientists at Washington University and elsewhere have found that a way to kill the virus by interfering with its replication.

The Brown School’s Douglas A. Luke, PhD, professor and director of the Center for Public Health Systems Science at Washington University in St. Louis, was on an Institute of Medicine committee which recently released guidelines to the U.S. Food and Drug Administration on using agent-based models to improve the effect of tobacco control policy on public health.

As part of her series of Senior Listening Sessions across Missouri, Sen. Claire McCaskill held a roundtable discussion with experts on retirement security, elder justice and healthy aging March 31 at the Brown School’s Goldfarb Hall. Among the roundtable participants were seven from Washington University in St. Louis.

​While the federal health-care law has reduced the number of uninsured people by about 10 million, challenges remain, including how to educate new enrollees about their coverage options. New research at Washington University shows that communicating information about the Affordable Care Act can be made simple.

Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients’ tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis. The research is a boost to cancer immunotherapy, a treatment strategy that unleashes the immune system to seek out and destroy cancer.